Cargando…

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma

BACKGROUND: It has recently been shown that NDRG2 mRNA is down-regulated or undetectable in several human cancers and cancer cell-lines. Although the function of NDRG2 is unknown, high NDRG2 expression correlates with improved prognosis in high-grade gliomas. The aim of this study has been to examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorentzen, Anders, Vogel, Lotte K, Lewinsky, Rikke H, Sæbø, Mona, Skjelbred, Camilla F, Godiksen, Sine, Hoff, Geir, Tveit, Kjell M, Lothe, Inger Marie Bowitz, Ikdahl, Tone, Kure, Elin H, Mitchelmore, Cathy
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2099434/ https://www.ncbi.nlm.nih.gov/pubmed/17935612 http://dx.doi.org/10.1186/1471-2407-7-192

Ejemplares similares

Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas
por: Skjelbred, Camilla F, et al.
Publicado: (2007)

Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
por: Lorentzen, Anders, et al.
Publicado: (2011)

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
por: Bornholdt, Jette, et al.
Publicado: (2011)

NDRG2 gene copy number is not altered in colorectal carcinoma
por: Lorentzen, Anders, et al.
Publicado: (2017)

Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study
por: Skjelbred, Camilla Furu, et al.
Publicado: (2006)

Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis
por: Vogel, Lotte K., et al.
Publicado: (2014)

Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas
por: Sæbø, Mona, et al.
Publicado: (2006)

Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas
por: Sæbø, Mona, et al.
Publicado: (2006)

Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study
por: Skjelbred, Camilla F, et al.
Publicado: (2006)

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals
por: Vogel, Lotte K, et al.
Publicado: (2006)

Correction: Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Collagen mRNA levels changes during colorectal cancer carcinogenesis
por: Skovbjerg, Hanne, et al.
Publicado: (2009)

Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing
por: Hamfjord, Julian, et al.
Publicado: (2012)

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2014)

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis
por: Selzer-Plon, Joanna, et al.
Publicado: (2009)

Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines
por: Wennerström, Anna B., et al.
Publicado: (2014)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

Opportunities of improvement in the management of pancreatic and periampullary tumors: Prospective evaluation of outcome from a multidisciplinary research program
por: Nordby, Tom, et al.
Publicado: (2013)

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
por: Tarpgaard, Line S., et al.
Publicado: (2014)

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2012)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

High ABCC2 and Low ABCG2 Gene Expression Are Early Events in the Colorectal Adenoma-Carcinoma Sequence
por: Andersen, Vibeke, et al.
Publicado: (2015)

The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study
por: Andersen, Vibeke, et al.
Publicado: (2009)

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer
por: Tarpgaard, Line S., et al.
Publicado: (2016)

Distribution of allele frequencies for genes associated with physical activity and/or physical capacity in a homogenous Norwegian cohort- a cross-sectional study
por: Goleva-Fjellet, Sannija, et al.
Publicado: (2020)

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
por: Hamfjord, Julian, et al.
Publicado: (2022)

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma
por: Vaitkiene, Paulina, et al.
Publicado: (2017)

Single-track sequencing for genotyping of multiple SNPs in the N-acetyltransferase 1 (NAT1) gene
por: Soucek, Pavel, et al.
Publicado: (2004)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
por: Thomsen, Maria, et al.
Publicado: (2018)

NDRG3-mediated lactate signaling in hypoxia
por: Park, Kyung Chan, et al.
Publicado: (2015)

High expression of NDRG3 in osteoarthritis patients
por: Chen, Long, et al.
Publicado: (2021)

NDRG1 protein overexpression in malignant thyroid neoplasms
por: Gerhard, Renê, et al.
Publicado: (2010)

NDRG2 as a marker protein for brain astrocytes
por: Flügge, Gabriele, et al.
Publicado: (2014)

Characterization of the prognostic values of the NDRG family in gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

Ndrg1 promotes adipocyte differentiation and sustains their function
por: Cai, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iuqivfd5frgd2dj68abst0ejaq